Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ubagai, T.
Right arrow Articles by Nakagama, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ubagai, T.
Right arrow Articles by Nakagama, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 23, No. 1, 197-200, January 2002
© 2002 Oxford University Press


SHORT COMMUNICATION

Efficient induction of rat large intestinal tumors with a new spectrum of mutations by intermittent administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in combination with a high fat diet

Tsuneyuki Ubagai1, Masako Ochiai1, Toshihiko Kawamori2, Hiroshi Imai3, Takashi Sugimura1, Minako Nagao1,4 and Hitoshi Nakagama1,5

1 Biochemistry Division and
2 Cancer Prevention Division, National Cancer Center Research Institute, 1-1 Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan,
3 Department of Pathology, School of Medicine, Mie University, Edobashi, Tsu, Mie 514-8507, Japan and
4 Applied Bioscience, Tokyo University of Agriculture, 1-1 Sakuragaoka 1-chome, Setagaya-ku, Tokyo 156-8502, Japan

In the present study we have established novel intermittent protocols featuring a high fat (HF) diet for efficient induction of large intestinal tumors with a relatively small amount of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). In protocol 1, F344 male rats were first fed a diet containing 400 p.p.m. PhIP for 2 weeks, followed by continuous administration of a HF diet without PhIP for 108 weeks. In protocol 2, 2 week PhIP treatments were repeated three times with 4 week intervals on the HF diet alone, followed by continuous feeding of the HF diet for 42 weeks. At termination of the experiments, 16 (3 of 19) and 45% (9 of 20) of the rats had developed a total of three and 13 large intestinal tumors with protocols 1 and 2, respectively. The tumor incidence in protocol 2 was comparable with that observed with continuous feeding of 400 p.p.m. PhIP for 52 weeks, after exposure to only ~10% of the amount of carcinogen. Five of nine (55%) tumors harbored mutations in either the ß-catenin or Apc gene, while all demonstrated accumulation of ß-catenin protein in the cytoplasm and nucleus. This suggests that other unknown genetic alterations in the Wnt–Apc–ß-catenin signaling pathway could have been involved in the development of tumors. By further modifying this intermittent protocol with HF diet, one could expect more efficient induction of lesions with much smaller amounts of PhIP in a shorter period. In addition, this model could provide a means to elucidate genetic alterations in large intestinal tumors induced by relatively low levels of carcinogenic insult, mimicking the cases of human colon carcinogenesis induced by exposure to environmental carcinogens.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
R. Wang, W.M. Dashwood, C. V. Lohr, K. A. Fischer, C. B. Pereira, M. Louderback, H. Nakagama, G. S. Bailey, D. E. Williams, and R. H. Dashwood
Protective versus promotional effects of white tea and caffeine on PhIP-induced tumorigenesis and {beta}-catenin expression in the rat
Carcinogenesis, April 1, 2008; 29(4): 834 - 839.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Tsuchiya, M. Ochiai, K. Nakashima, T. Ubagai, T. Sugimura, and H. Nakagama
SND1, a Component of RNA-Induced Silencing Complex, Is Up-regulated in Human Colon Cancers and Implicated in Early Stage Colon Carcinogenesis
Cancer Res., October 1, 2007; 67(19): 9568 - 9576.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
N. Currier, S. E. Solomon, E. G. Demicco, D. L. F. Chang, M. Farago, H. Ying, I. Dominguez, G. E. Sonenshein, R. D. Cardiff, Z.-X. J. Xiao, et al.
Oncogenic Signaling Pathways Activated in DMBA-Induced Mouse Mammary Tumors
Toxicol Pathol, October 1, 2005; 33(6): 726 - 737.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Tanaka, R. Suzuki, H. Kohno, S. Sugie, M. Takahashi, and K. Wakabayashi
Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess {beta}-catenin gene mutations and increases immunoreactivity for {beta}-catenin, cyclooxygenase-2 and inducible nitric oxide synthase
Carcinogenesis, January 1, 2005; 26(1): 229 - 238.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Kawamori, Y. Totsuka, N. Uchiya, T. Kitamura, H. Shibata, T. Sugimura, and K. Wakabayashi
Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats
Carcinogenesis, October 1, 2004; 25(10): 1967 - 1672.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Fujiwara, M. Ochiai, T. Ohta, M. Ohki, H. Aburatani, M. Nagao, T. Sugimura, and H. Nakagama
Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
Carcinogenesis, August 1, 2004; 25(8): 1495 - 1505.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Ochiai, M. Ushigome, K. Fujiwara, T. Ubagai, T. Kawamori, T. Sugimura, M. Nagao, and H. Nakagama
Characterization of Dysplastic Aberrant Crypt Foci in the Rat Colon Induced by 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine
Am. J. Pathol., October 1, 2003; 163(4): 1607 - 1614.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.